Hjem › Ikke-småcellet lungekreft › New York › Buffalo
Kliniske studier for Ikke-småcellet lungekreft i Buffalo, NY
19 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Buffalo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RekruttererFase 3
- Roswell Park Cancer Institute, Buffalo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Roswell Park Cancer Institute, Buffalo
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruttererFase 3
- Roswell Park Cancer Institute ( Site 0184), Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Roswell Park Cancer Institute IDS, Buffalo
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruttererFase 3
- Roswell Park Cancer Institute, Buffalo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
RekruttererFase 3
- Research Site, Buffalo
Intratumoral N17350 in Advanced Solid Tumors
RekruttererFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekruttererFase 2
- Research Site, Buffalo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Research Site, Buffalo
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
RekruttererFase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Comprehensive Care Center, Buffalo
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruttererFase 1
- Roswell Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Buffalo
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
Rekrutterer
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Roswell Park Cancer Institute, Buffalo
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Buffalo
- Kreft (alle typer)19 studier
- Akut myelogen leukemi19 studier
- Lungekreft16 studier
- Brystkreft16 studier
- Eggstokkreft13 studier
- Metastatisk kreft11 studier
- Prostatakreft11 studier
- Melanom10 studier
- Multipelt myelom10 studier
- Fedme9 studier
- Burkitts lymfom8 studier
- Myelodysplastiske syndromer8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.